Corvus hawaiiensis isolate bCorHaw1 chromosome 28, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036373.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC125317816, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC125317816, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125317819, transcript variant X1
uncharacterized LOC125317819, transcript variant X2
serine/threonine-protein kinase pim-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
platelet glycoprotein Ib alpha chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
platelet glycoprotein Ib alpha chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
platelet glycoprotein Ib alpha chain-like isoform X1
platelet glycoprotein Ib alpha chain-like isoform X2
COORDINATES: polyA evidence [ECO:0006239]
NADH:ubiquinone oxidoreductase subunit A11
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11
RAN binding protein 3, transcript variant X2
RAN binding protein 3, transcript variant X3
RAN binding protein 3, transcript variant X1
RAN binding protein 3, transcript variant X5
RAN binding protein 3, transcript variant X4
excitatory amino acid transporter 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
excitatory amino acid transporter 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
excitatory amino acid transporter 4-like, transcript variant X4
excitatory amino acid transporter 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
excitatory amino acid transporter 4-like, transcript variant X5
excitatory amino acid transporter 4-like, transcript variant X8
excitatory amino acid transporter 4-like, transcript variant X7
excitatory amino acid transporter 4-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
excitatory amino acid transporter 4-like isoform X2
excitatory amino acid transporter 4-like isoform X3
excitatory amino acid transporter 4-like isoform X1
lon protease homolog, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125317854, transcript variant X3
uncharacterized LOC125317854, transcript variant X4
uncharacterized LOC125317854, transcript variant X2
uncharacterized LOC125317854, transcript variant X1
uncharacterized LOC125317854, transcript variant X5
translocase of inner mitochondrial membrane 13
mitochondrial import inner membrane translocase subunit Tim13
transmembrane serine protease 9, transcript variant X3
transmembrane serine protease 9, transcript variant X1
transmembrane serine protease 9, transcript variant X4
transmembrane serine protease 9, transcript variant X2
transmembrane protease serine 9 isoform X2
transmembrane protease serine 9 isoform X3
transmembrane protease serine 9 isoform X1
transmembrane protease serine 9 isoform X4
signal peptide peptidase like 2B, transcript variant X1
signal peptide peptidase like 2B, transcript variant X2
signal peptide peptidase-like 2B isoform X1
signal peptide peptidase-like 2B isoform X2
signal peptide peptidase like 2B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
signal peptide peptidase-like 2B isoform X3
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated, transcript variant X1
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated, transcript variant X2
U6 snRNA-associated Sm-like protein LSm7 isoform X2
U6 snRNA-associated Sm-like protein LSm7 isoform X1
ceramide synthase 4-like, transcript variant X4
ceramide synthase 4-like, transcript variant X1
ceramide synthase 4-like, transcript variant X3
ceramide synthase 4-like, transcript variant X2
ceramide synthase 4-like, transcript variant X7
ceramide synthase 4-like, transcript variant X5
ceramide synthase 4-like, transcript variant X6
ceramide synthase 4-like, transcript variant X8
ceramide synthase 4-like, transcript variant X9
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: butyrophilin subfamily 3 member A2-like
E3 ubiquitin-protein ligase TRIM7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
E3 ubiquitin-protein ligase TRIM7-like, transcript variant X2
E3 ubiquitin-protein ligase TRIM7-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
membrane associated ring-CH-type finger 2, transcript variant X1
membrane associated ring-CH-type finger 2, transcript variant X2
membrane associated ring-CH-type finger 2, transcript variant X4
membrane associated ring-CH-type finger 2, transcript variant X3
E3 ubiquitin-protein ligase MARCHF2 isoform X2
E3 ubiquitin-protein ligase MARCHF2 isoform X1
KN motif and ankyrin repeat domains 3, transcript variant X3
KN motif and ankyrin repeat domains 3, transcript variant X1
KN motif and ankyrin repeat domains 3, transcript variant X5
KN motif and ankyrin repeat domains 3, transcript variant X4
KN motif and ankyrin repeat domains 3, transcript variant X2
KN motif and ankyrin repeat domain-containing protein 3 isoform X2
KN motif and ankyrin repeat domain-containing protein 3 isoform X3
KN motif and ankyrin repeat domain-containing protein 3 isoform X1
NADH:ubiquinone oxidoreductase subunit A7
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7
potassium voltage-gated channel subfamily V member 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
potassium voltage-gated channel subfamily V member 2-like, transcript variant X1
potassium voltage-gated channel subfamily V member 2-like isoform X1
potassium voltage-gated channel subfamily V member 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
DNA polymerase epsilon 4, accessory subunit
PML-RARA regulated adaptor molecule 1, transcript variant X1
PML-RARA regulated adaptor molecule 1, transcript variant X2
PML-RARA regulated adaptor molecule 1, transcript variant X3
PML-RARA-regulated adapter molecule 1 isoform X3
PML-RARA-regulated adapter molecule 1 isoform X1
PML-RARA-regulated adapter molecule 1 isoform X2
excitatory amino acid transporter 5-like, transcript variant X3
excitatory amino acid transporter 5-like, transcript variant X1
excitatory amino acid transporter 5-like, transcript variant X2
excitatory amino acid transporter 5-like isoform X1
excitatory amino acid transporter 5-like isoform X3
excitatory amino acid transporter 5-like isoform X2
ELAV like RNA binding protein 1, transcript variant X3
ELAV like RNA binding protein 1, transcript variant X1
ELAV like RNA binding protein 1, transcript variant X2
megakaryocyte-associated tyrosine kinase, transcript variant X6
megakaryocyte-associated tyrosine kinase, transcript variant X1
megakaryocyte-associated tyrosine kinase, transcript variant X2
megakaryocyte-associated tyrosine kinase, transcript variant X4
megakaryocyte-associated tyrosine kinase, transcript variant X5
megakaryocyte-associated tyrosine-protein kinase isoform X1
megakaryocyte-associated tyrosine-protein kinase isoform X3
megakaryocyte-associated tyrosine-protein kinase isoform X5
megakaryocyte-associated tyrosine kinase, transcript variant X3
megakaryocyte-associated tyrosine-protein kinase isoform X2
megakaryocyte-associated tyrosine-protein kinase isoform X4
retina and anterior neural fold homeobox 2
retina and anterior neural fold homeobox protein 2
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X2
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X8
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X4
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X5
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X7
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X6
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X3
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X1
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like isoform X7
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like isoform X3
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like isoform X4
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like isoform X6
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like isoform X5
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like isoform X2
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like isoform X1
39S ribosomal protein L54, mitochondrial
amyloid beta precursor protein binding family A member 3, transcript variant X1
amyloid beta precursor protein binding family A member 3, transcript variant X2
amyloid-beta A4 precursor protein-binding family A member 3 isoform X1
amyloid-beta A4 precursor protein-binding family A member 3 isoform X2
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X1
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X2
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X3
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X4
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X6
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X10
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X7
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X5
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
phosphatidylinositol-4-phosphate 5-kinase type 1 gamma, transcript variant X8
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X1
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X6
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X10
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X2
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X3
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X7
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X5
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X8
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X9
thromboxane A2 receptor, transcript variant X2
thromboxane A2 receptor, transcript variant X1
GIPC PDZ domain containing family member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
high mobility group 20B, transcript variant X2
high mobility group 20B, transcript variant X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related
major facilitator superfamily domain containing 12, transcript variant X1
major facilitator superfamily domain containing 12, transcript variant X3
major facilitator superfamily domain containing 12, transcript variant X2
major facilitator superfamily domain-containing protein 12 isoform X1
major facilitator superfamily domain-containing protein 12 isoform X2
major facilitator superfamily domain-containing protein 12 isoform X3
fizzy and cell division cycle 20 related 1, transcript variant X2
fizzy and cell division cycle 20 related 1, transcript variant X1
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1-like
deoxyhypusine hydroxylase, transcript variant X1
deoxyhypusine hydroxylase, transcript variant X2
nuclear factor I C, transcript variant X2
nuclear factor I C, transcript variant X1
nuclear factor I C, transcript variant X4
nuclear factor I C, transcript variant X3
nuclear factor I C, transcript variant X5
unc-13 homolog A, transcript variant X18
unc-13 homolog A, transcript variant X19
unc-13 homolog A, transcript variant X20
unc-13 homolog A, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
unc-13 homolog A, transcript variant X12
unc-13 homolog A, transcript variant X16
unc-13 homolog A, transcript variant X10
unc-13 homolog A, transcript variant X11
unc-13 homolog A, transcript variant X14
unc-13 homolog A, transcript variant X21
unc-13 homolog A, transcript variant X15
unc-13 homolog A, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125318006, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
uncharacterized LOC125318006, transcript variant X1
uncharacterized LOC125318006, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125318006, transcript variant X3
uncharacterized LOC125318006, transcript variant X5
uncharacterized protein LOC125318006 isoform X1
uncharacterized protein LOC125318006 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
methyl-CpG binding domain protein 3, transcript variant X1
methyl-CpG binding domain protein 3, transcript variant X2
methyl-CpG binding domain protein 3, transcript variant X3
methyl-CpG-binding domain protein 3 isoform X1
methyl-CpG-binding domain protein 3 isoform X3
methyl-CpG-binding domain protein 3 isoform X2
transcription factor 3, transcript variant X9
transcription factor 3, transcript variant X2
transcription factor 3, transcript variant X10
transcription factor 3, transcript variant X7
transcription factor 3, transcript variant X6
transcription factor 3, transcript variant X4
transcription factor 3, transcript variant X5
transcription factor 3, transcript variant X3
transcription factor 3, transcript variant X1
transcription factor E2-alpha isoform X10
transcription factor E2-alpha isoform X2
transcription factor E2-alpha isoform X9
transcription factor E2-alpha isoform X7
transcription factor E2-alpha isoform X6
transcription factor E2-alpha isoform X4
transcription factor E2-alpha isoform X5
transcription factor E2-alpha isoform X3
transcription factor E2-alpha isoform X1
transcription factor 3, transcript variant X8
transcription factor E2-alpha isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RNA exonuclease 1 homolog, transcript variant X2
RNA exonuclease 1 homolog, transcript variant X1
abhydrolase domain containing 17A, depalmitoylase
alpha/beta hydrolase domain-containing protein 17A
secretory carrier-associated membrane protein 4
casein kinase 1 gamma 2, transcript variant X1
casein kinase 1 gamma 2, transcript variant X2
MAPK interacting serine/threonine kinase 2
MAP kinase-interacting serine/threonine-protein kinase 2
MOB kinase activator 3A, transcript variant X1
MOB kinase activator 3A, transcript variant X3
MOB kinase activator 3A, transcript variant X2
adaptor related protein complex 3 subunit delta 1, transcript variant X1
adaptor related protein complex 3 subunit delta 1, transcript variant X2
DOT1 like histone lysine methyltransferase, transcript variant X1
DOT1 like histone lysine methyltransferase, transcript variant X3
DOT1 like histone lysine methyltransferase, transcript variant X4
DOT1 like histone lysine methyltransferase, transcript variant X7
DOT1 like histone lysine methyltransferase, transcript variant X6
DOT1 like histone lysine methyltransferase, transcript variant X8
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X7
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X1
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X3
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X6
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X4
DOT1 like histone lysine methyltransferase, transcript variant X2
DOT1 like histone lysine methyltransferase, transcript variant X5
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X2
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X5
pleckstrin homology domain containing J1
pleckstrin homology domain-containing family J member 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: splicing factor 3A subunit 2
anti-Mullerian hormone, transcript variant X1
anti-Mullerian hormone, transcript variant X2
cilia- and flagella-associated protein 251-like, transcript variant X1
cilia- and flagella-associated protein 251-like, transcript variant X3
cilia- and flagella-associated protein 251-like, transcript variant X2
cilia- and flagella-associated protein 251-like
LOW QUALITY PROTEIN: ornithine decarboxylase antizyme 1
leucine rich repeat and Ig domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
leucine rich repeat and Ig domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3
C2 calcium-dependent domain-containing protein 4B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 50% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tyrosine-protein kinase ZAP-70, transcript variant X2
tyrosine-protein kinase ZAP-70, transcript variant X4
tyrosine-protein kinase ZAP-70, transcript variant X3
tyrosine-protein kinase ZAP-70, transcript variant X1
tyrosine-protein kinase ZAP-70 isoform X3
tyrosine-protein kinase ZAP-70 isoform X2
tyrosine-protein kinase ZAP-70 isoform X1
ADAM metallopeptidase with thrombospondin type 1 motif 10
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: A disintegrin and metalloproteinase with thrombospondin motifs 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein 414, transcript variant X1
zinc finger protein 414, transcript variant X2
acidic leucine-rich nuclear phosphoprotein 32 family member B, transcript variant X2
acidic leucine-rich nuclear phosphoprotein 32 family member B, transcript variant X1
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X2
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X1
alkaline ceramidase 1, transcript variant X1
alkaline ceramidase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
MLLT1 super elongation complex subunit, transcript variant X1
MLLT1 super elongation complex subunit, transcript variant X2
acyl-CoA synthetase bubblegum family member 2, transcript variant X3
acyl-CoA synthetase bubblegum family member 2, transcript variant X4
acyl-CoA synthetase bubblegum family member 2, transcript variant X2
acyl-CoA synthetase bubblegum family member 2, transcript variant X1
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X2
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X1
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X3
DNA-binding protein RFX2-like, transcript variant X7
DNA-binding protein RFX2-like, transcript variant X4
DNA-binding protein RFX2-like, transcript variant X2
DNA-binding protein RFX2-like isoform X2
DNA-binding protein RFX2-like isoform X4
DNA-binding protein RFX2-like, transcript variant X1
DNA-binding protein RFX2-like, transcript variant X3
DNA-binding protein RFX2-like, transcript variant X5
DNA-binding protein RFX2-like, transcript variant X6
DNA-binding protein RFX2-like isoform X1
DNA-binding protein RFX2-like isoform X3
DNA-binding protein RFX2-like isoform X5
DNA-binding protein RFX2-like isoform X6
la-related protein 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
la-related protein 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gamma-interferon-inducible lysosomal thiol reductase
phosphoinositide-3-kinase regulatory subunit 2, transcript variant X1
phosphoinositide-3-kinase regulatory subunit 2, transcript variant X2
phosphatidylinositol 3-kinase regulatory subunit beta
microtubule associated serine/threonine kinase 3, transcript variant X2
microtubule associated serine/threonine kinase 3, transcript variant X10
microtubule associated serine/threonine kinase 3, transcript variant X7
microtubule associated serine/threonine kinase 3, transcript variant X1
microtubule associated serine/threonine kinase 3, transcript variant X9
microtubule associated serine/threonine kinase 3, transcript variant X4
microtubule associated serine/threonine kinase 3, transcript variant X6
microtubule associated serine/threonine kinase 3, transcript variant X3
microtubule associated serine/threonine kinase 3, transcript variant X5
microtubule-associated serine/threonine-protein kinase 3 isoform X10
microtubule-associated serine/threonine-protein kinase 3 isoform X7
microtubule-associated serine/threonine-protein kinase 3 isoform X2
microtubule-associated serine/threonine-protein kinase 3 isoform X1
microtubule-associated serine/threonine-protein kinase 3 isoform X9
microtubule-associated serine/threonine-protein kinase 3 isoform X4
microtubule-associated serine/threonine-protein kinase 3 isoform X6
microtubule-associated serine/threonine-protein kinase 3 isoform X5
microtubule-associated serine/threonine-protein kinase 3 isoform X3
microtubule associated serine/threonine kinase 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
microtubule-associated serine/threonine-protein kinase 3 isoform X8
interleukin 12 receptor subunit beta 1, transcript variant X4
interleukin 12 receptor subunit beta 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
interleukin 12 receptor subunit beta 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
interleukin 12 receptor subunit beta 1, transcript variant X2
interleukin-12 receptor subunit beta-1 isoform X3
interleukin-12 receptor subunit beta-1 isoform X1
interleukin-12 receptor subunit beta-1 isoform X2
interleukin-12 receptor subunit beta-1 isoform X4
arrestin domain containing 2, transcript variant X2
arrestin domain containing 2, transcript variant X1
arrestin domain-containing protein 2 isoform X2
arrestin domain-containing protein 2 isoform X1
peroxisomal biogenesis factor 11 gamma, transcript variant X3
peroxisomal biogenesis factor 11 gamma, transcript variant X4
peroxisomal biogenesis factor 11 gamma, transcript variant X1
peroxisomal biogenesis factor 11 gamma, transcript variant X2
peroxisomal membrane protein 11C isoform X1
peroxisomal membrane protein 11C isoform X2
peroxisomal membrane protein 11C isoform X3
ectoderm-neural cortex protein 1-like, transcript variant X1
ectoderm-neural cortex protein 1-like, transcript variant X2
ectoderm-neural cortex protein 1-like, transcript variant X3
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X4
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X3
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X1
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X2
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X6
Rho/Rac guanine nucleotide exchange factor 18, transcript variant X5
rho guanine nucleotide exchange factor 18 isoform X2
rho guanine nucleotide exchange factor 18 isoform X3
rho guanine nucleotide exchange factor 18 isoform X1
rho guanine nucleotide exchange factor 18 isoform X4
rho guanine nucleotide exchange factor 18 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
HAUS augmin like complex subunit 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
HAUS augmin like complex subunit 8, transcript variant X1
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X1
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X4
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X3
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X2
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X5
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
C3 and PZP like alpha-2-macroglobulin domain containing 8, transcript variant X6
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X1
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X4
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X6
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X3
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X2
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X5
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SIN3 transcription regulator family member B
NACHT domain- and WD repeat-containing protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: NACHT domain- and WD repeat-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
trimeric intracellular cation channel type A
mediator complex subunit 26, transcript variant X1
mediator of RNA polymerase II transcription subunit 26 isoform X1
mediator complex subunit 26, transcript variant X2
mediator complex subunit 26, transcript variant X3
mediator of RNA polymerase II transcription subunit 26 isoform X2
mediator complex subunit 26, transcript variant X4
mediator of RNA polymerase II transcription subunit 26 isoform X3
scaffold attachment factor B1-like, transcript variant X2
scaffold attachment factor B1-like, transcript variant X1
scaffold attachment factor B1-like isoform X2
scaffold attachment factor B1-like isoform X1
scaffold attachment factor B1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
scaffold attachment factor B1-like, transcript variant X5
scaffold attachment factor B1-like, transcript variant X4
mitochondrial contact site and cristae organizing system subunit 13
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X1
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X2
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X1
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X2
CUGBP Elav-like family member 5, transcript variant X2
CUGBP Elav-like family member 5, transcript variant X1
CUGBP Elav-like family member 5 isoform X2
CUGBP Elav-like family member 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
guanine nucleotide-binding protein subunit alpha-11
TLE family member 5, transcriptional modulator, transcript variant X2
TLE family member 5, transcriptional modulator, transcript variant X1
TLE family member 2, transcriptional corepressor, transcript variant X2
TLE family member 2, transcriptional corepressor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
TLE family member 2, transcriptional corepressor, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
TLE family member 2, transcriptional corepressor, transcript variant X3
TLE family member 2, transcriptional corepressor, transcript variant X1
TLE family member 2, transcriptional corepressor, transcript variant X5
TLE family member 2, transcriptional corepressor, transcript variant X4
TLE family member 2, transcriptional corepressor, transcript variant X8
transducin-like enhancer protein 2 isoform X1
transducin-like enhancer protein 2 isoform X2
transducin-like enhancer protein 2 isoform X4
transducin-like enhancer protein 2 isoform X3
transducin-like enhancer protein 2 isoform X5
transducin-like enhancer protein 2 isoform X7
transducin-like enhancer protein 2 isoform X6
transducin-like enhancer protein 1, transcript variant X2
transducin-like enhancer protein 1, transcript variant X1
transducin-like enhancer protein 1 isoform X2
transducin-like enhancer protein 1 isoform X1
transducin-like enhancer protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
MIER family member 2, transcript variant X8
MIER family member 2, transcript variant X4
MIER family member 2, transcript variant X9
MIER family member 2, transcript variant X2
MIER family member 2, transcript variant X1
MIER family member 2, transcript variant X3
MIER family member 2, transcript variant X7
MIER family member 2, transcript variant X6
MIER family member 2, transcript variant X5
MIER family member 2, transcript variant X10
mesoderm induction early response protein 2 isoform X5
mesoderm induction early response protein 2 isoform X3
mesoderm induction early response protein 2 isoform X6
mesoderm induction early response protein 2 isoform X1
mesoderm induction early response protein 2 isoform X2
mesoderm induction early response protein 2 isoform X4
mesoderm induction early response protein 2 isoform X7
C2 calcium dependent domain containing 4C
C2 calcium-dependent domain-containing protein 4C
SHC adaptor protein 2, transcript variant X3
SHC adaptor protein 2, transcript variant X2
SHC adaptor protein 2, transcript variant X1
SHC adaptor protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
hippocampus abundant transcript 1 protein-like
mucosal vascular addressin cell adhesion molecule 1
mucosal addressin cell adhesion molecule 1
tubulin polyglutamylase complex subunit 1, transcript variant X1
tubulin polyglutamylase complex subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
tubulin polyglutamylase complex subunit 1 isoform X1
tubulin polyglutamylase complex subunit 1 isoform X2
cell division cycle 34, ubiqiutin conjugating enzyme
basigin (Ok blood group), transcript variant X4
basigin (Ok blood group), transcript variant X5
basigin (Ok blood group), transcript variant X1
basigin (Ok blood group), transcript variant X2
basigin (Ok blood group), transcript variant X3
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2
DNA-directed RNA polymerase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mitotic interactor and substrate of PLK1
uncharacterized protein KIAA1958 homolog, transcript variant X3
uncharacterized protein KIAA1958 homolog, transcript variant X2
uncharacterized protein KIAA1958 homolog, transcript variant X1
uncharacterized protein KIAA1958 homolog isoform X3
uncharacterized protein KIAA1958 homolog isoform X2
uncharacterized protein KIAA1958-like isoform X1
polypyrimidine tract binding protein 1, transcript variant X2
polypyrimidine tract binding protein 1, transcript variant X1
polypyrimidine tract-binding protein 1 isoform X1
polypyrimidine tract-binding protein 1 isoform X2
phospholipid phosphatase related 3, transcript variant X1
phospholipid phosphatase related 3, transcript variant X2
phospholipid phosphatase-related protein type 3
mediator complex subunit 16, transcript variant X1
mediator complex subunit 16, transcript variant X2
mediator of RNA polymerase II transcription subunit 16
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
AT-rich interaction domain 3A, transcript variant X1
AT-rich interaction domain 3A, transcript variant X3
AT-rich interaction domain 3A, transcript variant X2
AT-rich interactive domain-containing protein 3A isoform X1
AT-rich interactive domain-containing protein 3A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
glutamate ionotropic receptor NMDA type subunit 3B, transcript variant X2
glutamate ionotropic receptor NMDA type subunit 3B, transcript variant X1
glutamate receptor ionotropic, NMDA 3B isoform X1
glutamate receptor ionotropic, NMDA 3B isoform X2
transmembrane protein 259, transcript variant X2
transmembrane protein 259, transcript variant X1
ATP binding cassette subfamily A member 7, transcript variant X2
ATP binding cassette subfamily A member 7, transcript variant X3
ATP binding cassette subfamily A member 7, transcript variant X6
ATP binding cassette subfamily A member 7, transcript variant X5
ATP binding cassette subfamily A member 7, transcript variant X4
ATP binding cassette subfamily A member 7, transcript variant X1
phospholipid-transporting ATPase ABCA7 isoform X3
phospholipid-transporting ATPase ABCA7 isoform X2
phospholipid-transporting ATPase ABCA7 isoform X4
phospholipid-transporting ATPase ABCA7 isoform X1
Rho GTPase activating protein 45, transcript variant X2
rho GTPase-activating protein 45 isoform X2
Rho GTPase activating protein 45, transcript variant X3
Rho GTPase activating protein 45, transcript variant X1
rho GTPase-activating protein 45 isoform X1
rho GTPase-activating protein 45 isoform X3
DNA-directed RNA polymerases I, II, and III subunit RPABC1
phospholipid hydroperoxide glutathione peroxidase
strawberry notch homolog 2, transcript variant X3
strawberry notch homolog 2, transcript variant X4
strawberry notch homolog 2, transcript variant X1
strawberry notch homolog 2, transcript variant X2
strawberry notch homolog 2, transcript variant X5
strawberry notch homolog 2, transcript variant X6
protein strawberry notch homolog 2 isoform X2
protein strawberry notch homolog 2 isoform X1
protein strawberry notch homolog 2 isoform X3
protein strawberry notch homolog 2 isoform X4
serine/threonine kinase 11, transcript variant X1
serine/threonine kinase 11, transcript variant X2
CACN subunit beta associated regulatory protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 10 bases in 8 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 10 bases in 8 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: voltage-dependent calcium channel beta subunit-associated regulatory protein
ATP synthase subunit delta, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
cold inducible RNA binding protein, transcript variant X4
cold inducible RNA binding protein, transcript variant X1
cold inducible RNA binding protein, transcript variant X3
cold inducible RNA binding protein, transcript variant X2
cold-inducible RNA-binding protein isoform X4
cold-inducible RNA-binding protein isoform X3
cold-inducible RNA-binding protein isoform X1
cold-inducible RNA-binding protein isoform X2
family with sequence similarity 174 member C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type IV-like
LOW QUALITY PROTEIN: calcium/calmodulin-dependent protein kinase type IV-like
PWWP domain containing 3A, DNA repair factor
PWWP domain-containing DNA repair factor 3A
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
NADH:ubiquinone oxidoreductase core subunit S7
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial
guanidinoacetate N-methyltransferase, transcript variant X1
guanidinoacetate N-methyltransferase, transcript variant X2
DAZ associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
DAZ associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
DAZ associated protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
APC regulator of WNT signaling pathway 2
LOW QUALITY PROTEIN: adenomatous polyposis coli protein 2
chromosome 28 C19orf25 homolog, transcript variant X4
chromosome 28 C19orf25 homolog, transcript variant X6
chromosome 28 C19orf25 homolog, transcript variant X1
chromosome 28 C19orf25 homolog, transcript variant X3
chromosome 28 C19orf25 homolog, transcript variant X2
chromosome 28 C19orf25 homolog, transcript variant X5
chromosome 28 C19orf25 homolog, transcript variant X7
chromosome 28 C19orf25 homolog, transcript variant X8
receptor accessory protein 6, transcript variant X2
receptor accessory protein 6, transcript variant X1
receptor accessory protein 6, transcript variant X3
receptor expression-enhancing protein 6 isoform X2
receptor expression-enhancing protein 6 isoform X1
receptor expression-enhancing protein 6 isoform X3
proprotein convertase subtilisin/kexin type 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
inactive serine/threonine-protein kinase PLK5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inactive serine/threonine-protein kinase PLK5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: thimet oligopeptidase
small glutamine rich tetratricopeptide repeat co-chaperone alpha
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: small glutamine-rich tetratricopeptide repeat-containing protein alpha
solute carrier family 39 member 3, transcript variant X1
solute carrier family 39 member 3, transcript variant X2
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7
growth arrest and DNA damage inducible beta
growth arrest and DNA damage-inducible protein GADD45 beta
cocaine- and amphetamine-regulated transcript protein-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: microtubule-associated protein 1S
FCH and mu domain containing endocytic adaptor 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: F-BAR domain only protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 5 member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 5 member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 124
potassium calcium-activated channel subfamily N member 1, transcript variant X1
potassium calcium-activated channel subfamily N member 1, transcript variant X3
potassium calcium-activated channel subfamily N member 1, transcript variant X2
potassium calcium-activated channel subfamily N member 1, transcript variant X4
small conductance calcium-activated potassium channel protein 1 isoform X1
small conductance calcium-activated potassium channel protein 1 isoform X3
small conductance calcium-activated potassium channel protein 1 isoform X2
small conductance calcium-activated potassium channel protein 1 isoform X4
occludin/ELL domain-containing protein 1
nuclear receptor subfamily 2 group F member 6, transcript variant X27
nuclear receptor subfamily 2 group F member 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X2
nuclear receptor subfamily 2 group F member 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6 isoform X3
nuclear receptor subfamily 2 group F member 6 isoform X5
nuclear receptor subfamily 2 group F member 6 isoform X1
nuclear receptor subfamily 2 group F member 6, transcript variant X8
nuclear receptor subfamily 2 group F member 6, transcript variant X5
nuclear receptor subfamily 2 group F member 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X13
nuclear receptor subfamily 2 group F member 6, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6 isoform X7
nuclear receptor subfamily 2 group F member 6 isoform X11
nuclear receptor subfamily 2 group F member 6 isoform X14
nuclear receptor subfamily 2 group F member 6 isoform X8
nuclear receptor subfamily 2 group F member 6 isoform X4
nuclear receptor subfamily 2 group F member 6 isoform X2
nuclear receptor subfamily 2 group F member 6, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X18
nuclear receptor subfamily 2 group F member 6 isoform X6
nuclear receptor subfamily 2 group F member 6 isoform X20
nuclear receptor subfamily 2 group F member 6 isoform X16
nuclear receptor subfamily 2 group F member 6, transcript variant X11
nuclear receptor subfamily 2 group F member 6, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6 isoform X9
nuclear receptor subfamily 2 group F member 6, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6 isoform X10
nuclear receptor subfamily 2 group F member 6, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X19
nuclear receptor subfamily 2 group F member 6, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
nuclear receptor subfamily 2 group F member 6 isoform X17
nuclear receptor subfamily 2 group F member 6 isoform X13
nuclear receptor subfamily 2 group F member 6 isoform X21
nuclear receptor subfamily 2 group F member 6 isoform X19
nuclear receptor subfamily 2 group F member 6 isoform X18
nuclear receptor subfamily 2 group F member 6 isoform X15
nuclear receptor subfamily 2 group F member 6 isoform X12
nuclear receptor subfamily 2 group F member 6, transcript variant X25
nuclear receptor subfamily 2 group F member 6, transcript variant X24
nuclear receptor subfamily 2 group F member 6 isoform X22
nuclear receptor subfamily 2 group F member 6, transcript variant X26
nuclear receptor subfamily 2 group F member 6 isoform X23
uncharacterized LOC125317999, transcript variant X2
uncharacterized LOC125317999, transcript variant X1
USH1 protein network component harmonin binding protein 1, transcript variant X7
USH1 protein network component harmonin binding protein 1, transcript variant X5
USH1 protein network component harmonin binding protein 1, transcript variant X6
USH1 protein network component harmonin binding protein 1, transcript variant X4
USH1 protein network component harmonin binding protein 1, transcript variant X3
USH1 protein network component harmonin binding protein 1, transcript variant X2
USH1 protein network component harmonin binding protein 1, transcript variant X1
Usher syndrome type-1C protein-binding protein 1 isoform X4
Usher syndrome type-1C protein-binding protein 1 isoform X3
Usher syndrome type-1C protein-binding protein 1 isoform X2
Usher syndrome type-1C protein-binding protein 1 isoform X1
Usher syndrome type-1C protein-binding protein 1 isoform X5
USH1 protein network component harmonin binding protein 1, transcript variant X8
Usher syndrome type-1C protein-binding protein 1 isoform X6
ankyrin repeat and LEM domain containing 1
ankyrin repeat and LEM domain-containing protein 1
collagen alpha-1(III) chain-like, transcript variant X1
collagen alpha-1(III) chain-like, transcript variant X4
collagen alpha-1(III) chain-like, transcript variant X3
collagen alpha-1(III) chain-like, transcript variant X2
collagen alpha-1(III) chain-like isoform X1
basic proline-rich protein-like isoform X4
basic proline-rich protein-like isoform X3
basic proline-rich protein-like isoform X2
abhydrolase domain containing 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
abhydrolase domain containing 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
abhydrolase domain containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
39S ribosomal protein L34, mitochondrial
uncharacterized LOC125317948, transcript variant X1
uncharacterized LOC125317948, transcript variant X3
uncharacterized protein LOC125317948 isoform X1
uncharacterized protein LOC125317948 isoform X3
uncharacterized LOC125317948, transcript variant X2
uncharacterized LOC125317948, transcript variant X4
uncharacterized LOC125317948, transcript variant X7
uncharacterized LOC125317948, transcript variant X5
uncharacterized LOC125317948, transcript variant X6
uncharacterized protein LOC125317948 isoform X2
uncharacterized protein LOC125317948 isoform X4
uncharacterized protein LOC125317948 isoform X7
uncharacterized protein LOC125317948 isoform X5
uncharacterized protein LOC125317948 isoform X6
collagen alpha-2(IV) chain-like, transcript variant X4
collagen alpha-2(IV) chain-like, transcript variant X1
collagen alpha-2(IV) chain-like, transcript variant X5
collagen alpha-2(IV) chain-like, transcript variant X6
collagen alpha-2(IV) chain-like, transcript variant X3
collagen alpha-2(IV) chain-like, transcript variant X2
collagen alpha-2(IV) chain-like, transcript variant X8
collagen alpha-2(IV) chain-like, transcript variant X9
collagen alpha-2(IV) chain-like, transcript variant X7
collagen alpha-2(IV) chain-like, transcript variant X21
collagen alpha-2(IV) chain-like, transcript variant X31
uncharacterized protein LOC125317919 isoform X4
uncharacterized protein LOC125317919 isoform X1
uncharacterized protein LOC125317919 isoform X5
uncharacterized protein LOC125317919 isoform X6
uncharacterized protein LOC125317919 isoform X3
uncharacterized protein LOC125317919 isoform X2
uncharacterized protein LOC125317919 isoform X8
uncharacterized protein LOC125317919 isoform X9
uncharacterized protein LOC125317919 isoform X7
uncharacterized protein LOC125317919 isoform X21
collagen alpha-2(IV) chain-like, transcript variant X19
collagen alpha-2(IV) chain-like, transcript variant X26
collagen alpha-2(IV) chain-like, transcript variant X29
collagen alpha-2(IV) chain-like, transcript variant X30
collagen alpha-2(IV) chain-like, transcript variant X14
collagen alpha-2(IV) chain-like, transcript variant X10
collagen alpha-2(IV) chain-like, transcript variant X25
collagen alpha-2(IV) chain-like, transcript variant X13
collagen alpha-2(IV) chain-like, transcript variant X11
collagen alpha-2(IV) chain-like, transcript variant X16
collagen alpha-2(IV) chain-like, transcript variant X20
collagen alpha-2(IV) chain-like, transcript variant X24
collagen alpha-2(IV) chain-like, transcript variant X28
collagen alpha-2(IV) chain-like, transcript variant X22
collagen alpha-2(IV) chain-like, transcript variant X12
collagen alpha-2(IV) chain-like, transcript variant X18
collagen alpha-2(IV) chain-like, transcript variant X23
collagen alpha-2(IV) chain-like, transcript variant X27
collagen alpha-2(IV) chain-like, transcript variant X15
collagen alpha-2(IV) chain-like, transcript variant X17
uncharacterized protein LOC125317919 isoform X19
uncharacterized protein LOC125317919 isoform X14
uncharacterized protein LOC125317919 isoform X10
uncharacterized protein LOC125317919 isoform X13
uncharacterized protein LOC125317919 isoform X11
uncharacterized protein LOC125317919 isoform X16
uncharacterized protein LOC125317919 isoform X20
uncharacterized protein LOC125317919 isoform X12
collagen alpha-2(IV) chain-like isoform X15
uncharacterized protein LOC125317919 isoform X17
collagen alpha-5(IV) chain-like isoform X26
collagen alpha-3(IV) chain-like isoform X29
collagen alpha-5(IV) chain-like isoform X30
collagen alpha-2(IV) chain-like isoform X25
collagen alpha-5(IV) chain-like isoform X24
collagen alpha-2(IV) chain-like isoform X28
collagen alpha-5(IV) chain-like isoform X22
collagen alpha-5(IV) chain-like isoform X18
collagen alpha-5(IV) chain-like isoform X23
collagen alpha-2(IV) chain-like isoform X27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
GTP binding protein 3, mitochondrial, transcript variant X5
GTP binding protein 3, mitochondrial, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
GTP binding protein 3, mitochondrial, transcript variant X3
GTP binding protein 3, mitochondrial, transcript variant X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X3
tRNA modification GTPase GTPBP3, mitochondrial isoform X4
GTP binding protein 3, mitochondrial, transcript variant X2
tRNA modification GTPase GTPBP3, mitochondrial isoform X2
YjeF N-terminal domain containing 3, transcript variant X2
YjeF N-terminal domain containing 3, transcript variant X1
yjeF N-terminal domain-containing protein 3 isoform X2
yjeF N-terminal domain-containing protein 3 isoform X1
NADH:ubiquinone oxidoreductase subunit A13
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13
GATA zinc finger domain containing 2A, transcript variant X5
GATA zinc finger domain containing 2A, transcript variant X1
GATA zinc finger domain containing 2A, transcript variant X3
GATA zinc finger domain containing 2A, transcript variant X2
GATA zinc finger domain containing 2A, transcript variant X4
transcriptional repressor p66-alpha isoform X4
transcriptional repressor p66-alpha isoform X3
transcriptional repressor p66-alpha isoform X2
transcriptional repressor p66-alpha isoform X1
transcriptional repressor p66-alpha isoform X5
uncharacterized LOC125317998, transcript variant X2
uncharacterized LOC125317998, transcript variant X1
uncharacterized LOC125317998, transcript variant X5
uncharacterized LOC125317998, transcript variant X3
uncharacterized LOC125317998, transcript variant X4
SURP and G-patch domain containing 1, transcript variant X1
SURP and G-patch domain containing 1, transcript variant X2
SURP and G-patch domain containing 1, transcript variant X3
SURP and G-patch domain-containing protein 1 isoform X1
SURP and G-patch domain-containing protein 1 isoform X2
SURP and G-patch domain-containing protein 1 isoform X3
hyaluronan and proteoglycan link protein 4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
LOW QUALITY PROTEIN: hyaluronan and proteoglycan link protein 4
LOW QUALITY PROTEIN: neurocan core protein
regulatory factor X associated ankyrin containing protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
myocyte enhancer factor 2B, transcript variant X1
myocyte enhancer factor 2B, transcript variant X2
collagen alpha-1(XXIII) chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
collagen alpha-1(XXIII) chain-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
collagen alpha-1(XXIII) chain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
collagen alpha-1(XXIII) chain-like, transcript variant X1
collagen alpha-1(XXIII) chain-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
solute carrier family 25 member 42, transcript variant X4
mitochondrial coenzyme A transporter SLC25A42 isoform X2
solute carrier family 25 member 42, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
solute carrier family 25 member 42, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
solute carrier family 25 member 42, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mitochondrial coenzyme A transporter SLC25A42 isoform X1
armadillo repeat containing 6, transcript variant X4
armadillo repeat containing 6, transcript variant X5
armadillo repeat containing 6, transcript variant X1
armadillo repeat containing 6, transcript variant X2
armadillo repeat-containing protein 6 isoform X2
armadillo repeat-containing protein 6 isoform X1
armadillo repeat-containing protein 6 isoform X4
armadillo repeat containing 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
armadillo repeat-containing protein 6 isoform X3
SURP and G-patch domain containing 2, transcript variant X1
SURP and G-patch domain containing 2, transcript variant X6
SURP and G-patch domain containing 2, transcript variant X3
SURP and G-patch domain containing 2, transcript variant X5
SURP and G-patch domain containing 2, transcript variant X4
SURP and G-patch domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
SURP and G-patch domain-containing protein 2 isoform X2
SURP and G-patch domain-containing protein 2 isoform X1
SURP and G-patch domain-containing protein 2 isoform X3
homer scaffold protein 3, transcript variant X1
homer scaffold protein 3, transcript variant X2
probable ATP-dependent RNA helicase DDX49
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
embryonic growth/differentiation factor 1
UPF1 RNA helicase and ATPase, transcript variant X2
UPF1 RNA helicase and ATPase, transcript variant X1
regulator of nonsense transcripts 1 isoform X2
regulator of nonsense transcripts 1 isoform X1
cartilage oligomeric matrix protein, transcript variant X1
cartilage oligomeric matrix protein, transcript variant X3
cartilage oligomeric matrix protein, transcript variant X2
cartilage oligomeric matrix protein isoform X1
cartilage oligomeric matrix protein isoform X2
CREB regulated transcription coactivator 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
CREB regulated transcription coactivator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
CREB regulated transcription coactivator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
CREB regulated transcription coactivator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
CREB regulated transcription coactivator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
CREB regulated transcription coactivator 1, transcript variant X7
CREB regulated transcription coactivator 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
CREB-regulated transcription coactivator 1 isoform X5
CREB-regulated transcription coactivator 1 isoform X2
CREB-regulated transcription coactivator 1 isoform X7
CREB-regulated transcription coactivator 1 isoform X6
CREB-regulated transcription coactivator 1 isoform X4
CREB-regulated transcription coactivator 1 isoform X3
CREB-regulated transcription coactivator 1 isoform X1
uncharacterized LOC125317875, transcript variant X1
uncharacterized LOC125317875, transcript variant X2
kelch like family member 26, transcript variant X1
kelch like family member 26, transcript variant X3
kelch like family member 26, transcript variant X2
transmembrane protein 59 like, transcript variant X2
transmembrane protein 59 like, transcript variant X1
transmembrane protein 59-like isoform X2
transmembrane protein 59-like isoform X1
transmembrane protein 59 like, transcript variant X3
cytokine receptor like factor 1, transcript variant X1
cytokine receptor like factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
cytokine receptor-like factor 1 isoform X1
cytokine receptor-like factor 1 isoform X2
required for excision 1-B domain containing
required for excision 1-B domain-containing protein
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant X1
ubiquitin A-52 residue ribosomal protein fusion product 1, transcript variant X2
FKBP prolyl isomerase 8, transcript variant X2
FKBP prolyl isomerase 8, transcript variant X1
peptidyl-prolyl cis-trans isomerase FKBP8
LOW QUALITY PROTEIN: inositol-3-phosphate synthase 1
single-stranded DNA-binding protein 3-like
LOW QUALITY PROTEIN: single-stranded DNA-binding protein 3-like
growth differentiation factor 15, transcript variant X1
growth differentiation factor 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
growth/differentiation factor 15 isoform X1
growth/differentiation factor 15 isoform X2
pyroglutamyl-peptidase I, transcript variant X2
pyroglutamyl-peptidase I, transcript variant X1
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm4
JunD proto-oncogene, AP-1 transcription factor subunit
phosphodiesterase 4C, transcript variant X3
phosphodiesterase 4C, transcript variant X1
phosphodiesterase 4C, transcript variant X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X2
phosphodiesterase 4C, transcript variant X4
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X4
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X3
uncharacterized LOC125317721, transcript variant X2
uncharacterized LOC125317721, transcript variant X3
uncharacterized LOC125317721, transcript variant X1
MPV17 mitochondrial inner membrane protein like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
MPV17 mitochondrial inner membrane protein like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
MPV17 mitochondrial inner membrane protein like 2, transcript variant X2
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like
uncharacterized LOC125317724, transcript variant X1
uncharacterized LOC125317724, transcript variant X2
uncharacterized LOC125317724, transcript variant X3
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6-like
ATCAY kinesin light chain interacting caytaxin, transcript variant X2
ATCAY kinesin light chain interacting caytaxin, transcript variant X1
ATCAY kinesin light chain interacting caytaxin, transcript variant X3
eukaryotic translation elongation factor 2
COORDINATES: nucleotide motif:Rfam:12.0:RF00440
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger and BTB domain containing 7A, transcript variant X1
zinc finger and BTB domain containing 7A, transcript variant X2
zinc finger and BTB domain-containing protein 7A
mitogen-activated protein kinase kinase 2
dual specificity mitogen-activated protein kinase kinase 2
cAMP responsive element binding protein 3 like 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cyclic AMP-responsive element-binding protein 3-like protein 3
NAD-dependent protein deacetylase sirtuin-6 isoform X2
NAD-dependent protein deacetylase sirtuin-6 isoform X1
NAD-dependent protein deacetylase sirtuin-6 isoform X3
ankyrin repeat domain 24, transcript variant X2
ankyrin repeat domain-containing protein 24 isoform X2
ankyrin repeat domain 24, transcript variant X1
ankyrin repeat domain-containing protein 24 isoform X1
uncharacterized LOC125317717, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC125317717, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
translocase of inner mitochondrial membrane 44
mitochondrial import inner membrane translocase subunit TIM44
heterogeneous nuclear ribonucleoprotein M, transcript variant X2
heterogeneous nuclear ribonucleoprotein M, transcript variant X1
heterogeneous nuclear ribonucleoprotein M, transcript variant X3
heterogeneous nuclear ribonucleoprotein M, transcript variant X4
heterogeneous nuclear ribonucleoprotein M isoform X3
heterogeneous nuclear ribonucleoprotein M isoform X2
heterogeneous nuclear ribonucleoprotein M isoform X1
heterogeneous nuclear ribonucleoprotein M isoform X4
Src homology 2 domain containing transforming protein D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transmembrane and immunoglobulin domain containing 2
transmembrane and immunoglobulin domain-containing protein 2
fibronectin type III and SPRY domain containing 1, transcript variant X1
fibronectin type III and SPRY domain containing 1, transcript variant X2
fibronectin type III and SPRY domain-containing protein 1 isoform X1
fibronectin type III and SPRY domain-containing protein 1 isoform X2
MPN domain containing, transcript variant X1
MPN domain containing, transcript variant X2
MPN domain containing, transcript variant X5
MPN domain containing, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
MPN domain containing, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
MPN domain-containing protein isoform X1
MPN domain-containing protein isoform X2
MPN domain-containing protein isoform X4
MPN domain-containing protein isoform X3
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X1
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X3
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X2
hepatoma-derived growth factor-related protein 2 isoform X1
hepatoma-derived growth factor-related protein 2 isoform X2
hepatoma-derived growth factor-related protein 2 isoform X3
hepatoma-derived growth factor-related protein 2 isoform X4
TNF alpha induced protein 8 like 1, transcript variant X2
TNF alpha induced protein 8 like 1, transcript variant X1
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X1
TNF alpha induced protein 8 like 1, transcript variant X3
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X2
procathepsin L-like, transcript variant X1
procathepsin L-like, transcript variant X2
procathepsin L-like, transcript variant X3
dipeptidyl peptidase 9, transcript variant X1
dipeptidyl peptidase 9, transcript variant X3
dipeptidyl peptidase 9, transcript variant X2
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC125317702, transcript variant X3
uncharacterized LOC125317702, transcript variant X5
uncharacterized LOC125317702, transcript variant X8
uncharacterized LOC125317702, transcript variant X4
uncharacterized LOC125317702, transcript variant X2
uncharacterized LOC125317702, transcript variant X1
uncharacterized LOC125317702, transcript variant X7
uncharacterized LOC125317702, transcript variant X11
uncharacterized LOC125317702, transcript variant X6
uncharacterized LOC125317702, transcript variant X10
uncharacterized LOC125317702, transcript variant X9
TIR domain containing adaptor molecule 1
TIR domain-containing adapter molecule 1
ubiquitin like with PHD and ring finger domains 1, transcript variant X1
ubiquitin like with PHD and ring finger domains 1, transcript variant X2
E3 ubiquitin-protein ligase UHRF1 isoform X1
ubiquitin like with PHD and ring finger domains 1, transcript variant X3
E3 ubiquitin-protein ligase UHRF1 isoform X2
lysine demethylase 4B, transcript variant X2
lysine demethylase 4B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
lysine demethylase 4B, transcript variant X1
lysine demethylase 4B, transcript variant X3
lysine demethylase 4B, transcript variant X4
lysine-specific demethylase 4B isoform X1
lysine-specific demethylase 4B isoform X2
lysine-specific demethylase 4B isoform X3
lysine-specific demethylase 4B isoform X5
lysine demethylase 4B, transcript variant X5
lysine-specific demethylase 4B isoform X4
protein tyrosine phosphatase receptor type S, transcript variant X16
protein tyrosine phosphatase receptor type S, transcript variant X14
protein tyrosine phosphatase receptor type S, transcript variant X13
protein tyrosine phosphatase receptor type S, transcript variant X15
protein tyrosine phosphatase receptor type S, transcript variant X22
protein tyrosine phosphatase receptor type S, transcript variant X12
protein tyrosine phosphatase receptor type S, transcript variant X11
protein tyrosine phosphatase receptor type S, transcript variant X9
protein tyrosine phosphatase receptor type S, transcript variant X10
protein tyrosine phosphatase receptor type S, transcript variant X6
protein tyrosine phosphatase receptor type S, transcript variant X21
protein tyrosine phosphatase receptor type S, transcript variant X4
protein tyrosine phosphatase receptor type S, transcript variant X19
protein tyrosine phosphatase receptor type S, transcript variant X2
protein tyrosine phosphatase receptor type S, transcript variant X18
protein tyrosine phosphatase receptor type S, transcript variant X20
protein tyrosine phosphatase receptor type S, transcript variant X17
protein tyrosine phosphatase receptor type S, transcript variant X5
protein tyrosine phosphatase receptor type S, transcript variant X8
protein tyrosine phosphatase receptor type S, transcript variant X3
protein tyrosine phosphatase receptor type S, transcript variant X7
protein tyrosine phosphatase receptor type S, transcript variant X1
receptor-type tyrosine-protein phosphatase S isoform X19
receptor-type tyrosine-protein phosphatase S isoform X12
receptor-type tyrosine-protein phosphatase S isoform X11
receptor-type tyrosine-protein phosphatase S isoform X9
receptor-type tyrosine-protein phosphatase S isoform X10
receptor-type tyrosine-protein phosphatase S isoform X6
receptor-type tyrosine-protein phosphatase S isoform X18
receptor-type tyrosine-protein phosphatase S isoform X4
receptor-type tyrosine-protein phosphatase S isoform X16
receptor-type tyrosine-protein phosphatase S isoform X2
receptor-type tyrosine-protein phosphatase S isoform X15
receptor-type tyrosine-protein phosphatase S isoform X17
receptor-type tyrosine-protein phosphatase S isoform X14
receptor-type tyrosine-protein phosphatase S isoform X5
receptor-type tyrosine-protein phosphatase S isoform X8
receptor-type tyrosine-protein phosphatase S isoform X3
receptor-type tyrosine-protein phosphatase S isoform X7
receptor-type tyrosine-protein phosphatase S isoform X1
receptor-type tyrosine-protein phosphatase S isoform X13
uncharacterized LOC125317863, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC125317863, transcript variant X2
uncharacterized LOC125317863, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC125317863, transcript variant X7
uncharacterized LOC125317863, transcript variant X5
uncharacterized LOC125317863, transcript variant X3
uncharacterized LOC125317863, transcript variant X6
uncharacterized LOC125318018, transcript variant X1
uncharacterized LOC125318018, transcript variant X2
uncharacterized LOC125318018, transcript variant X3
uncharacterized LOC125318018, transcript variant X4
TINCR ubiquitin domain containing, transcript variant X1
TINCR ubiquitin domain containing isoform X1
TINCR ubiquitin domain containing, transcript variant X4
TINCR ubiquitin domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TINCR ubiquitin domain containing isoform X2
TINCR ubiquitin domain containing, transcript variant X3
TINCR ubiquitin domain containing isoform X3
RAB8A, member RAS oncogene family, transcript variant X2
RAB8A, member RAS oncogene family, transcript variant X1
calcium and integrin binding family member 3
calcium and integrin-binding family member 3
family with sequence similarity 32 member A
adaptor related protein complex 1 subunit mu 1
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X2
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X1
epidermal growth factor receptor substrate 15-like 1 isoform X2
epidermal growth factor receptor substrate 15-like 1 isoform X1
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X3
epidermal growth factor receptor substrate 15-like 1 isoform X3
uncharacterized protein C19orf44 homolog
calcium homeostasis endoplasmic reticulum protein, transcript variant X2
calcium homeostasis endoplasmic reticulum protein, transcript variant X3
calcium homeostasis endoplasmic reticulum protein, transcript variant X1
calcium homeostasis endoplasmic reticulum protein isoform X3
calcium homeostasis endoplasmic reticulum protein isoform X2
calcium homeostasis endoplasmic reticulum protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns